Liposome of irinotecan or irinotecan hydrochloride and preparation method thereof
US10022365B2 · kind B2 · utility
2Cited by
2References
23Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 21, 2017 |
| Grant date | Jul 17, 2018 |
| Priority date | — |
| Expiry date | Mar 21, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A liposome of irinotecan or irinotecan hydrochloride and its preparation method are disclosed. The liposome contains irinotecan or irinotecan hydrochloride, neutral phospholipid and cholesterol, wherein the weight ratio of the cholesterol to the neutral phospholipid is 1:3 to 1:5. The liposome is prepared by an ion gradient method.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.